Mural Oncology (MURA) Expected to Announce Quarterly Earnings on Tuesday

Mural Oncology (NASDAQ:MURA - Get Free Report) is expected to be announcing its earnings results before the market opens on Tuesday, March 25th. Analysts expect the company to announce earnings of ($1.98) per share for the quarter.

Mural Oncology (NASDAQ:MURA - Get Free Report) last announced its quarterly earnings data on Tuesday, March 11th. The company reported ($2.01) EPS for the quarter, missing analysts' consensus estimates of ($1.96) by ($0.05). During the same quarter in the prior year, the firm earned ($3.57) EPS. On average, analysts expect Mural Oncology to post $-8 EPS for the current fiscal year and $-5 EPS for the next fiscal year.

Mural Oncology Price Performance

Shares of Mural Oncology stock traded down $0.03 during trading on Friday, hitting $3.84. 36,175 shares of the stock were exchanged, compared to its average volume of 157,935. The firm's 50-day moving average price is $3.91 and its 200 day moving average price is $3.61. The stock has a market cap of $66.16 million, a price-to-earnings ratio of -0.42 and a beta of 3.66. Mural Oncology has a 12-month low of $2.87 and a 12-month high of $5.12.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reaffirmed a "buy" rating and set a $18.00 price objective on shares of Mural Oncology in a research report on Wednesday, March 12th.

About Mural Oncology

Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab.